Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Butler-Laporte

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
The Lancet. Diabetes & Endocrinology|December 17, 2022
Mendelian randomisation and vitamin D: the importance of model assumptionsGuillaume Butler-Laporte, J Brent Richards
The Lancet. Diabetes & Endocrinology|October 31, 2021
WITHDRAWN: Targeting of vitamin D supplementation to individuals with deficiencyGuillaume Butler-Laporte, J Brent Richards
Lancet (London, England)|October 24, 2021
Antibiotic treatment duration for bacteraemic pneumoniaGuillaume Butler-Laporte, Alex Halme, Camille Simard
The European Respiratory Journal|September 19, 2015
Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatmentNicholas Winters, Guillaume Butler-Laporte, Dick Menzies
The Journal of Infectious Diseases|May 28, 2025
Mendelian Randomization and Infection: Pitfalls and PromisesFergus Hamilton, Guillaume Butler-Laporte, George Davey Smith
Antimicrobial Agents and Chemotherapy|April 25, 2018
Increasing Rates of Penicillin Sensitivity in Staphylococcus aureusGuillaume Butler-Laporte, Todd C Lee, Matthew P Cheng
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 2, 2020
Tocilizumab versus the Covid19 tempest: All's well that ends well or much ado about nothing?Todd C Lee, Guillaume Butler-Laporte, Zain Chagla, et al.
BMC Infectious Diseases|June 13, 2018
Screening swabs surpass traditional risk factors as predictors of MRSA bacteremiaGuillaume Butler-Laporte, Matthew P Cheng, Emily G McDonald, et al.
Infection Control and Hospital Epidemiology|January 25, 2020
Using VRE screening tests to predict vancomycin resistance in enterococcal bacteremiaGuillaume Butler-Laporte, Matthew P Cheng, Emily G McDonald, et al.
Trials|May 31, 2018
Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trialMatthew P Cheng, Alexander Lawandi, Guillaume Butler-Laporte, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
The Lancet. Diabetes & Endocrinology|December 17, 2022
Mendelian randomisation and vitamin D: the importance of model assumptionsGuillaume Butler-Laporte, J Brent Richards
The Lancet. Diabetes & Endocrinology|October 31, 2021
WITHDRAWN: Targeting of vitamin D supplementation to individuals with deficiencyGuillaume Butler-Laporte, J Brent Richards
Lancet (London, England)|October 24, 2021
Antibiotic treatment duration for bacteraemic pneumoniaGuillaume Butler-Laporte, Alex Halme, Camille Simard
The European Respiratory Journal|September 19, 2015
Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatmentNicholas Winters, Guillaume Butler-Laporte, Dick Menzies
The Journal of Infectious Diseases|May 28, 2025
Mendelian Randomization and Infection: Pitfalls and PromisesFergus Hamilton, Guillaume Butler-Laporte, George Davey Smith
Antimicrobial Agents and Chemotherapy|April 25, 2018
Increasing Rates of Penicillin Sensitivity in Staphylococcus aureusGuillaume Butler-Laporte, Todd C Lee, Matthew P Cheng
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 2, 2020
Tocilizumab versus the Covid19 tempest: All's well that ends well or much ado about nothing?Todd C Lee, Guillaume Butler-Laporte, Zain Chagla, et al.
BMC Infectious Diseases|June 13, 2018
Screening swabs surpass traditional risk factors as predictors of MRSA bacteremiaGuillaume Butler-Laporte, Matthew P Cheng, Emily G McDonald, et al.
Infection Control and Hospital Epidemiology|January 25, 2020
Using VRE screening tests to predict vancomycin resistance in enterococcal bacteremiaGuillaume Butler-Laporte, Matthew P Cheng, Emily G McDonald, et al.
Trials|May 31, 2018
Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trialMatthew P Cheng, Alexander Lawandi, Guillaume Butler-Laporte, et al.
Pageof 9